Australian experience of amikacin in NTM disease

Amikacin causes little toxicity in carefully selected and closely monitored patients with non-tuberculous mycobacterial (NTM) disease but is less effective than previously thought, according to a case series published by Brisbane respiratory physicians. Dr Claire Ellender, from the Princess Alexandra Hospital, and colleagues described 45 patients treated at three Brisbane hospitals between 2002 and 2012. ...